Arya Mariam Roy

Assistant Professor

Ohio State University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

The human epidermal growth factor receptors (HERs) are expressed abundantly in the human body. The tumorigenic potential of HER2/neu is linked to its overexpression, amplification or somatic mutation. The HER2 gene amplification leading to protein overexpression has been reported in 25–30% of breast cancers and 10–30% of gastric/gastroesophageal cancers. While HER2 is a well-documented predictive, prognostic, and therapeutic marker in breast and gastric/gastroesophageal cancers, its relevance has also been demonstrated in multiple other malignancies. In this article, we will conduct an extensive review of current data pertaining to HER2 amplification, overexpression, or mutation in cancers other than breast and gastric cancers.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Ruth M. O’Regan

University of Rochester

UNITED STATES
View details

Ariela Marshall

Faculty, Associate Professor

University of Minnesota

UNITED STATES
View details

Zeynep Irem Ozay

University of Utah Health Huntsman Cancer Institute

UNITED STATES
View details

Joseph Elijah

Assistant Clinical Professor

Northeastern University

UNITED STATES
View details

Lubna Chaudhary

Assistant Professor

Medical College of Wisconsin

UNITED STATES
View details

Shipra Gandhi

Emory University

UNITED STATES
View details

Kazuaki Takabe

Alfiero Foundation Chair and Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES
View details

Sindhu Janarthanam Malapati

University of Arkansas for Medical Sciences

UNITED STATES
View details